277 related articles for article (PubMed ID: 21686325)
1. Coordinated gene expression of Th17- and Treg-associated molecules correlated with resolution of the monophasic experimental autoimmune uveitis.
Jia X; Hu M; Wang C; Wang C; Zhang F; Han Q; Zhao R; Huang Q; Xu H; Yuan H; Ren H
Mol Vis; 2011; 17():1493-507. PubMed ID: 21686325
[TBL] [Abstract][Full Text] [Related]
2. Longdan Xiegan Decoction alleviates experimental autoimmune uveitis in rats by inhibiting Notch signaling pathway activation and Th17 cell differentiation.
Yin X; Qiu Y; Li Z; Guo L; Wei H; Liu B; Zhou M; Li T; Wang L; Jiang W; Bi H; Guo D
Biomed Pharmacother; 2021 Apr; 136():111291. PubMed ID: 33493870
[TBL] [Abstract][Full Text] [Related]
3. Activation of the Notch signaling pathway disturbs the CD4
Yin X; Liu B; Wei H; Wu S; Guo L; Xu F; Liu T; Bi H; Guo D
Inflamm Res; 2019 Sep; 68(9):761-774. PubMed ID: 31209505
[TBL] [Abstract][Full Text] [Related]
4. SLAT/Def6 plays a critical role in the pathogenic process of experimental autoimmune uveitis (EAU).
Vistica BP; Shi G; Nugent L; Tan C; Altman A; Gery I
Mol Vis; 2012; 18():1858-64. PubMed ID: 22815639
[TBL] [Abstract][Full Text] [Related]
5. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis.
Haruta H; Ohguro N; Fujimoto M; Hohki S; Terabe F; Serada S; Nomura S; Nishida K; Kishimoto T; Naka T
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3264-71. PubMed ID: 21330657
[TBL] [Abstract][Full Text] [Related]
6. Oral administration of retinoic acid receptor-alpha/beta-specific ligand Am80 suppresses experimental autoimmune uveoretinitis.
Keino H; Watanabe T; Sato Y; Okada AA
Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1548-56. PubMed ID: 20861477
[TBL] [Abstract][Full Text] [Related]
7. [Effects of leflunomide on experimental autoimmune uveitis in Lewis rats].
Fang C; Zhou D; Zhan S; He Y; Lin Z; Huang C; Li J
Zhonghua Yan Ke Za Zhi; 2015 Oct; 51(10):754-61. PubMed ID: 26693771
[TBL] [Abstract][Full Text] [Related]
8. CTLA4-Ig suppresses development of experimental autoimmune uveitis in the induction and effector phases: Comparison with blockade of interleukin-6.
Iwahashi C; Fujimoto M; Nomura S; Serada S; Nakai K; Ohguro N; Nishida K; Naka T
Exp Eye Res; 2015 Nov; 140():53-64. PubMed ID: 26297802
[TBL] [Abstract][Full Text] [Related]
9. Imbalance Between Th17 Cells and Regulatory T Cells During Monophasic Experimental Autoimmune Uveitis.
Zhang L; Wan F; Song J; Tang K; Zheng F; Guo J; Guo D; Bi H
Inflammation; 2016 Feb; 39(1):113-122. PubMed ID: 26296290
[TBL] [Abstract][Full Text] [Related]
10. Contribution of CD4+CD25+ T cells to the regression phase of experimental autoimmune uveoretinitis.
Sun M; Yang P; Du L; Zhou H; Ren X; Kijlstra A
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):383-9. PubMed ID: 19696173
[TBL] [Abstract][Full Text] [Related]
11. Dynamics of intraocular IFN-γ, IL-17 and IL-10-producing cell populations during relapsing and monophasic rat experimental autoimmune uveitis.
Kaufmann U; Diedrichs-Möhring M; Wildner G
PLoS One; 2012; 7(11):e49008. PubMed ID: 23155443
[TBL] [Abstract][Full Text] [Related]
12. Reactivation of uveitogenic T cells by retinal astrocytes derived from experimental autoimmune uveitis-prone B10RIII mice.
Jiang G; Ke Y; Sun D; Han G; Kaplan HJ; Shao H
Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):282-9. PubMed ID: 18172104
[TBL] [Abstract][Full Text] [Related]
13. Effector T cells driving monophasic vs. relapsing/remitting experimental autoimmune uveitis show unique pathway signatures.
von Toerne C; Sieg C; Kaufmann U; Diedrichs-Möhring M; Nelson PJ; Wildner G
Mol Immunol; 2010; 48(1-3):272-80. PubMed ID: 20727594
[TBL] [Abstract][Full Text] [Related]
14. Ocular regulatory T cells distinguish monophasic from recurrent autoimmune uveitis.
Ke Y; Jiang G; Sun D; Kaplan HJ; Shao H
Invest Ophthalmol Vis Sci; 2008 Sep; 49(9):3999-4007. PubMed ID: 18487362
[TBL] [Abstract][Full Text] [Related]
15. Differentially expressed genes in MHC-compatible rat strains that are susceptible or resistant to experimental autoimmune uveitis.
Mattapallil MJ; Augello A; Cheadle C; Teichberg D; Becker KG; Chan CC; Mattapallil JJ; Pennesi G; Caspi RR
Invest Ophthalmol Vis Sci; 2008 May; 49(5):1957-70. PubMed ID: 18281616
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells ameliorate experimental autoimmune uveoretinitis by comprehensive modulation of systemic autoimmunity.
Zhang X; Ren X; Li G; Jiao C; Zhang L; Zhao S; Wang J; Han ZC; Li X
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3143-52. PubMed ID: 21296818
[TBL] [Abstract][Full Text] [Related]
17. Invariant NKT cells regulate experimental autoimmune uveitis through inhibition of Th17 differentiation.
Oh K; Byoun OJ; Ham DI; Kim YS; Lee DS
Eur J Immunol; 2011 Feb; 41(2):392-402. PubMed ID: 21268009
[TBL] [Abstract][Full Text] [Related]
18. Induction of antigen-specific Treg cells in treating autoimmune uveitis via bystander suppressive pathways without compromising anti-tumor immunity.
Chen Z; Zhang T; Kam HT; Qiao D; Jin W; Zhong Y; Zhou M; Zhou H; Chong WP; Chen W; Chen J
EBioMedicine; 2021 Aug; 70():103496. PubMed ID: 34280776
[TBL] [Abstract][Full Text] [Related]
19. Amelioration of experimental autoimmune uveitis by leflunomide in Lewis rats.
Fang CB; Zhou DX; Zhan SX; He Y; Lin Z; Huang C; Li J
PLoS One; 2013; 8(4):e62071. PubMed ID: 23626769
[TBL] [Abstract][Full Text] [Related]
20. Regulatory role of TLR ligands on the activation of autoreactive T cells by retinal astrocytes.
Jiang G; Ke Y; Sun D; Wang Y; Kaplan HJ; Shao H
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4769-76. PubMed ID: 19443727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
